Petco Health and Wellness (WOOF) Financials

$2.56 -0.07 (-2.47%)

As of 10:54 AM Eastern

Annual Income Statements for Petco Health and Wellness

This table shows Petco Health and Wellness' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Net Income / (Loss) Attributable to Common Shareholders	-96	-26	164	91	-1,280	-102
Consolidated Net Income / (Loss)	-104	-32	160	90	-1,280	-102
Net Income / (Loss) Continuing Operations	-104	-32	160	90	-1,280	-102
Total Pre-Tax Income	-142	-42	202	112	-1,324	-128
Total Operating Income	111	194	266	226	-1,180	7.05
Total Gross Profit	1,907	2,107	2,427	2,427	2,354	2,324
Total Revenue	4,435	4,920	5,807	6,036	6,255	6,116
Operating Revenue	4,435	4,920	5,807	6,036	6,255	6,116
Total Cost of Revenue	2,528	2,813	3,381	3,609	3,901	3,792
Operating Cost of Revenue	2,528	2,813	3,381	3,609	3,901	3,792
Total Operating Expenses	1,796	1,912	2,161	2,202	3,534	2,317
Selling, General & Admin Expense	1,777	1,912	2,161	2,202	2,312	2,317
Impairment Charge	19	0.00	0.00	0.00	1,223	0.00
Total Other Income / (Expense), net	-253	-236	-64	-113	-144	-135
Interest Expense	253	237	98	102	152	144
Interest & Investment Income	0.34	0.65	0.06	1.03	3.41	3.71
Other Income / (Expense), net	0.00	0.00	34	-13	4.73	4.80
Income Tax Expense	-36	-3.34	53	35	-28	-7.48
Other Gains / (Losses), net	2.44	6.48	11	13	16	19
Net Income / (Loss) Attributable to Noncontrolling Interest	-8.11	-5.25	-4.61	-0.89	0.00	0.00
Basic Earnings per Share	($0.46)	($0.13)	$0.62	$0.34	($4.78)	($0.37)
Weighted Average Basic Shares Outstanding	208.93M	210.68M	264.26M	265.52M	267.55M	273.41M
Diluted Earnings per Share	($0.46)	($0.13)	$0.62	$0.34	($4.78)	($0.37)
Weighted Average Diluted Shares Outstanding	208.93M	210.68M	265.34M	265.95M	267.55M	273.41M
Weighted Average Basic & Diluted Shares Outstanding	-	-	303.03M	304.55M	307.37M	315.13M

This table shows Petco Health and Wellness' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/29/2022	1/28/2023	4/29/2023	7/29/2023	10/28/2023	2/3/2024	5/4/2024	8/3/2024	11/2/2024	2/1/2025	5/3/2025
Net Income / (Loss) Attributable to Common Shareholders	20	33	-1.89	-15	-1,241	-23	-46	-25	-17	-14	-12
Consolidated Net Income / (Loss)	20	33	-1.89	-15	-1,241	-23	-46	-25	-17	-14	-12
Net Income / (Loss) Continuing Operations	20	33	-1.89	-15	-1,241	-23	-46	-25	-17	-14	-12
Total Pre-Tax Income	21	42	-6.03	-11	-1,268	-39	-56	-34	-22	-16	-16
Total Operating Income	48	78	28	24	-1,232	0.17	-17	2.47	3.98	17	16
Total Gross Profit	598	627	604	593	550	606	579	581	576	589	570
Total Revenue	1,501	1,578	1,556	1,531	1,494	1,674	1,529	1,524	1,511	1,552	1,493
Operating Revenue	1,501	1,578	1,556	1,531	1,494	1,674	1,529	1,524	1,511	1,552	1,493
Total Cost of Revenue	904	951	951	938	944	1,068	950	943	936	963	923
Operating Cost of Revenue	904	951	951	938	944	1,068	950	943	936	963	923
Total Operating Expenses	550	550	577	569	1,782	606	595	578	572	572	554
Selling, General & Admin Expense	550	550	577	569	560	606	595	578	572	572	554
Total Other Income / (Expense), net	-27	-35	-31	-35	-35	-42	-39	-36	-26	-39	-32
Interest Expense	27	33	38	38	37	40	37	37	36	34	33
Interest & Investment Income	0.13	0.75	4.31	0.76	1.14	-2.81	0.42	0.67	1.35	-3.61	1.36
Other Income / (Expense), net	0.58	-3.30	2.82	1.80	0.11	-	-2.67	0.00	8.47	-1.00	0.00
Income Tax Expense	4.16	15	-1.01	6.73	-23	-10	-4.48	-4.65	-0.86	2.50	0.50
Other Gains / (Losses), net	2.63	5.16	-	3.33	3.57	-	4.89	4.19	4.48	-	4.61
Basic Earnings per Share	$0.07	$0.13	($0.01)	($0.05)	($4.63)	($0.09)	($0.17)	($0.09)	($0.06)	($0.05)	($0.04)
Weighted Average Basic Shares Outstanding	265.69M	265.52M	266.49K	267.16K	267.85M	267.55M	269.77M	273.07M	274.50M	273.41M	277.55M
Diluted Earnings per Share	$0.07	$0.13	($0.01)	($0.05)	($4.63)	($0.09)	($0.17)	($0.09)	($0.06)	($0.05)	($0.04)
Weighted Average Diluted Shares Outstanding	265.94M	265.95M	266.49K	267.16K	267.85M	267.55M	269.77M	273.07M	274.50M	273.41M	277.55M
Weighted Average Basic & Diluted Shares Outstanding	303.71M	304.55M	304.80M	305.56M	306.28M	307.37M	310.78M	312.15M	313.45M	315.13M	316.78M

This table details how cash moves in and out of Petco Health and Wellness' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Net Change in Cash & Equivalents	-32	-35	102	-8.16	-77	45
Net Cash From Operating Activities	110	269	358	346	216	178
Net Cash From Continuing Operating Activities	110	269	358	346	216	178
Net Income / (Loss) Continuing Operations	-104	-32	160	90	-1,280	-102
Consolidated Net Income / (Loss)	-104	-32	160	90	-1,280	-102
Depreciation Expense	174	175	172	194	201	200
Amortization Expense	23	24	5.80	4.94	4.97	4.90
Non-Cash Adjustments To Reconcile Net Income	483	481	458	485	1,716	447
Changes in Operating Assets and Liabilities, net	-465	-379	-438	-428	-426	-372
Net Cash From Investing Activities	-139	-157	-237	-320	-207	-124
Net Cash From Continuing Investing Activities	-139	-157	-237	-320	-207	-124
Purchase of Property, Plant & Equipment	-157	-160	-239	-278	-226	-128
Acquisitions	-3.26	0.00	-4.33	-45	-6.73	-0.63
Purchase of Investments	-0.59	-1.00	0.00	0.00	0.00	-0.46
Sale of Property, Plant & Equipment	0.00	3.30	0.23	2.34	0.00	1.37
Sale and/or Maturity of Investments	0.00	0.07	6.14	0.00	25	1.00
Other Investing Activities, net	21	0.00	0.00	0.00	0.00	2.81
Net Cash From Financing Activities	-3.07	-147	-19	-34	-85	-8.75
Net Cash From Continuing Financing Activities	-3.07	-147	-19	-34	-85	-8.75
Repayment of Debt	-1,293	-1,555	-1,716	-140	-348	-204
Issuance of Debt	1,297	476	1,700	123	273	201
Issuance of Common Equity	0.24	936	0.00	0.00	0.00	2.50
Other Financing Activities, net	-7.01	-3.65	0.59	-17	-10	-8.23
Cash Interest Paid	219	179	66	91	143	139
Cash Income Taxes Paid	15	2.39	16	14	32	35

This table details how cash moves in and out of Petco Health and Wellness' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/29/2022	1/28/2023	4/29/2023	7/29/2023	10/28/2023	2/3/2024	5/4/2024	8/3/2024	11/2/2024	2/1/2025	5/3/2025
Net Change in Cash & Equivalents	24	62	-62	25	-34	-5.59	-46	43	-13	61	-43
Net Cash From Operating Activities	109	137	38	97	34	47	-8.41	69	21	96	-15
Net Cash From Continuing Operating Activities	109	137	38	97	34	47	-8.41	69	21	96	-15
Net Income / (Loss) Continuing Operations	20	33	-1.89	-15	-1,241	-23	-46	-25	-17	-14	-12
Consolidated Net Income / (Loss)	20	33	-1.89	-15	-1,241	-23	-46	-25	-17	-14	-12
Depreciation Expense	48	50	49	49	51	52	50	50	50	50	49
Amortization Expense	1.24	1.25	1.24	1.21	1.21	1.31	1.22	1.22	1.23	1.24	1.25
Non-Cash Adjustments To Reconcile Net Income	119	124	124	126	1,343	123	121	114	103	109	107
Changes in Operating Assets and Liabilities, net	-79	-72	-134	-65	-119	-107	-134	-71	-117	-50	-162
Net Cash From Investing Activities	-81	-68	-63	-43	-50	-51	-32	-26	-31	-34	-27
Net Cash From Continuing Investing Activities	-81	-68	-63	-43	-50	-51	-32	-26	-31	-34	-27
Purchase of Property, Plant & Equipment	-76	-66	-62	-52	-63	-49	-33	-27	-31	-37	-28
Acquisitions	-4.86	-1.89	-0.73	-1.32	-2.46	-2.23	-0.10	-0.16	-0.21	-0.17	0.00
Sale of Property, Plant & Equipment	-	0.21	-	-	-	-	0.00	-	0.23	0.12	1.28
Sale and/or Maturity of Investments	-	-	0.00	10	15	-	1.00	-	-	-	0.00
Net Cash From Financing Activities	-4.70	-6.81	-37	-29	-18	-1.31	-5.63	-0.27	-1.91	-0.95	-0.33
Net Cash From Continuing Financing Activities	-4.70	-6.81	-37	-29	-18	-1.31	-5.63	-0.27	-1.91	-0.95	-0.33
Repayment of Debt	-123	-4.25	-35	-25	-15	-273	-176	-28	-	-	0.00
Issuance of Debt	119	-	0.00	-	-	273	173	28	-	-	0.00
Issuance of Common Equity	0.88	-3.47	1.38	-1.38	-	-	0.83	1.67	-	-	0.97
Other Financing Activities, net	-1.33	0.91	-3.46	-2.31	-3.27	-1.31	-3.50	-1.86	-1.91	-0.95	-1.30
Cash Interest Paid	25	30	37	35	35	36	34	35	36	34	31
Cash Income Taxes Paid	4.14	4.85	8.93	18	3.84	0.93	1.28	14	9.07	10	0.63

This table presents Petco Health and Wellness' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Total Assets	6,076	5,473	6,613	5,363	5,194
Total Current Assets	778	1,071	1,016	952	974
Cash & Equivalents	111	212	202	125	166
Accounts Receivable	42	56	50	44	40
Inventories, net	539	675	652	685	653
Prepaid Expenses	40	42	51	59	54
Other Current Assets	46	86	61	39	61
Plant, Property, & Equipment, net	628	727	803	816	725
Plant, Property & Equipment, gross	-	-	-	-	2,266
Accumulated Depreciation	-	-	-	-	1,540
Total Noncurrent Assets	4,671	3,675	4,794	3,595	3,495
Goodwill	2,179	2,184	2,194	980	980
Intangible Assets	1,025	-	1,025	1,025	1,025
Other Noncurrent Operating Assets	1,466	1,491	1,575	1,590	1,490
Total Liabilities & Shareholders' Equity	6,076	6,498	6,613	5,363	5,194
Total Liabilities	4,020	4,242	4,231	4,179	4,081
Total Current Liabilities	875	1,053	1,021	1,113	1,139
Short-Term Debt	2.20	-	23	16	5.35
Accounts Payable	339	404	381	485	493
Accrued Expenses	146	211	218	200	177
Current Employee Benefit Liabilities	129	151	90	101	157
Other Current Liabilities	258	266	310	311	306
Total Noncurrent Liabilities	3,145	3,189	3,210	3,066	2,942
Long-Term Debt	1,646	1,640	1,628	1,576	1,578
Noncurrent Deferred & Payable Income Tax Liabilities	281	318	303	252	218
Other Noncurrent Operating Liabilities	1,218	1,230	1,279	1,238	1,146
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,055	2,256	2,381	1,184	1,114
Total Preferred & Common Equity	2,069	2,274	2,381	1,184	1,114
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,069	2,274	2,381	1,184	1,114
Common Stock	2,092	2,134	2,153	2,230	2,281
Retained Earnings	-22	142	233	-1,047	-1,149
Accumulated Other Comprehensive Income / (Loss)	-1.28	-2.24	-4.10	1.82	-18

This table presents Petco Health and Wellness' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	7/30/2022	10/29/2022	4/29/2023	7/29/2023	10/28/2023	5/4/2024	8/3/2024	11/2/2024	5/3/2025
Total Assets	6,542	6,577	6,572	6,662	5,427	5,259	5,277	5,211	5,121
Total Current Assets	1,014	1,019	977	1,025	1,008	904	942	932	920
Cash & Equivalents	125	149	149	173	140	90	128	117	133
Accounts Receivable	45	46	45	66	50	42	47	40	36
Inventories, net	723	723	668	675	730	681	672	690	645
Prepaid Expenses	54	44	53	55	47	65	60	47	67
Other Current Assets	67	57	61	55	41	26	35	38	39
Plant, Property, & Equipment, net	771	792	812	820	828	779	760	740	704
Plant, Property & Equipment, gross	1,873	1,938	2,042	2,090	2,143	2,177	2,207	2,234	2,285
Accumulated Depreciation	1,101	1,146	1,229	1,270	1,315	1,399	1,447	1,494	1,580
Total Noncurrent Assets	4,757	4,766	4,783	4,817	3,591	3,576	3,575	3,540	3,496
Goodwill	2,187	2,192	2,194	2,197	976	980	980	980	980
Intangible Assets	1,025	1,025	1,025	1,025	1,025	1,025	1,025	1,025	1,025
Other Noncurrent Operating Assets	1,546	1,549	1,564	1,596	1,590	1,571	1,570	1,535	1,491
Total Liabilities & Shareholders' Equity	6,542	6,577	6,572	6,662	5,427	5,259	5,277	5,211	5,121
Total Liabilities	4,263	4,249	4,171	4,247	4,234	4,097	4,145	4,089	4,014
Total Current Liabilities	1,035	1,057	997	1,075	1,115	1,069	1,118	1,114	1,083
Short-Term Debt	22	23	5.91	5.08	5.08	3.68	5.10	5.29	5.37
Accounts Payable	417	385	394	478	487	465	474	448	474
Accrued Expenses	220	220	207	220	216	198	197	191	190
Current Employee Benefit Liabilities	104	125	109	91	101	95	135	129	109
Other Current Liabilities	272	305	282	281	306	308	307	340	305
Total Noncurrent Liabilities	3,228	3,192	3,174	3,173	3,119	3,027	3,027	2,975	2,930
Long-Term Debt	1,634	1,631	1,612	1,589	1,575	1,574	1,576	1,577	1,579
Noncurrent Deferred & Payable Income Tax Liabilities	327	298	298	294	271	241	220	211	208
Other Noncurrent Operating Liabilities	131	1,262	1,265	1,290	1,273	1,212	1,232	1,187	1,143
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,279	2,328	2,401	2,415	1,193	1,162	1,131	1,123	1,107
Total Preferred & Common Equity	2,279	2,328	2,401	2,415	1,193	1,162	1,131	1,123	1,107
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,279	2,328	2,401	2,415	1,193	1,162	1,131	1,123	1,107
Common Stock	2,103	2,132	2,174	2,197	2,213	2,247	2,261	2,271	2,289
Retained Earnings	180	200	231	216	-1,025	-1,094	-1,119	-1,135	-1,161
Accumulated Other Comprehensive Income / (Loss)	-4.61	-4.52	-3.59	1.79	4.54	9.01	-11	-13	-20

This table displays calculated financial ratios and metrics derived from Petco Health and Wellness' official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	10.95%	18.03%	3.94%	3.63%	-2.22%
EBITDA Growth	0.00%	27.93%	21.68%	-14.02%	-335.59%	122.32%
EBIT Growth	0.00%	75.79%	54.59%	-29.17%	-652.20%	101.01%
NOPAT Growth	0.00%	75.79%	43.85%	-21.06%	-634.59%	100.60%
Net Income Growth	0.00%	69.48%	603.54%	-43.74%	-1,523.88%	92.05%
EPS Growth	0.00%	71.74%	576.92%	-45.16%	-1,505.88%	92.26%
Operating Cash Flow Growth	0.00%	143.45%	33.36%	-3.41%	-37.65%	-17.64%
Free Cash Flow Firm Growth	0.00%	0.00%	132.02%	-189.88%	135.51%	-64.67%
Invested Capital Growth	0.00%	0.00%	-25.36%	42.86%	-30.79%	-4.52%
Revenue Q/Q Growth	0.00%	0.00%	-13.89%	1.06%	1.57%	-1.96%
EBITDA Q/Q Growth	0.00%	0.00%	10.79%	-3.41%	-8.03%	7.06%
EBIT Q/Q Growth	0.00%	0.00%	20.16%	-7.80%	-6.73%	371.13%
NOPAT Q/Q Growth	0.00%	0.00%	15.14%	-5.21%	-7.02%	169.32%
Net Income Q/Q Growth	0.00%	0.00%	1.93%	6.45%	-4.52%	7.90%
EPS Q/Q Growth	0.00%	0.00%	31.91%	6.25%	-4.82%	9.76%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.74%	23.91%	-29.33%	38.05%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-13,317.90%	-17.46%	231.68%
Invested Capital Q/Q Growth	0.00%	0.00%	-26.79%	-0.06%	0.69%	-2.20%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	42.99%	42.82%	41.79%	40.21%	37.63%	38.00%
EBITDA Margin	6.94%	8.00%	8.24%	6.82%	-15.50%	3.54%
Operating Margin	2.49%	3.95%	4.58%	3.74%	-18.87%	0.12%
EBIT Margin	2.49%	3.95%	5.18%	3.53%	-18.79%	0.19%
Profit (Net Income) Margin	-2.34%	-0.65%	2.75%	1.49%	-20.47%	-1.66%
Tax Burden Percent	73.19%	76.37%	78.96%	80.08%	96.69%	79.56%
Interest Burden Percent	-128.47%	-21.37%	67.34%	52.74%	112.63%	-1,079.79%
Effective Tax Rate	0.00%	0.00%	26.42%	31.48%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	7.58%	6.24%	4.75%	-25.49%	0.19%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-14.26%	2.58%	-2.15%	-56.63%	-7.21%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-10.67%	1.17%	-0.87%	-46.31%	-9.05%
Return on Equity (ROE)	0.00%	-3.09%	7.41%	3.88%	-71.80%	-8.86%
Cash Return on Invested Capital (CROIC)	0.00%	-192.42%	35.28%	-30.55%	10.90%	4.82%
Operating Return on Assets (OROA)	0.00%	3.20%	5.21%	3.52%	-19.63%	0.22%
Return on Assets (ROA)	0.00%	-0.52%	2.77%	1.49%	-21.38%	-1.93%
Return on Common Equity (ROCE)	0.00%	-3.11%	7.47%	3.89%	-71.80%	-8.86%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-1.53%	7.03%	3.78%	-108.09%	-9.14%
Net Operating Profit after Tax (NOPAT)	77	136	196	155	-826	4.94
NOPAT Margin	1.75%	2.77%	3.37%	2.56%	-13.21%	0.08%
Net Nonoperating Expense Percent (NNEP)	0.00%	21.84%	3.67%	6.90%	31.14%	7.40%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	3.83%	-29.76%	0.18%
Cost of Revenue to Revenue	57.01%	57.18%	58.21%	59.79%	62.37%	62.00%
SG&A Expenses to Revenue	40.07%	38.87%	37.20%	36.47%	36.95%	37.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	40.50%	38.87%	37.20%	36.47%	56.50%	37.89%
Earnings before Interest and Taxes (EBIT)	111	194	301	213	-1,176	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	308	393	479	412	-970	216
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.60	2.43	1.50	0.64	0.96
Price to Tangible Book Value (P/TBV)	0.00	0.00	61.43	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.19	0.25	0.95	0.59	0.12	0.18
Price to Earnings (P/E)	0.00	0.00	33.64	39.27	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	2.97%	2.55%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.77	2.59	1.31	0.84	0.98
Enterprise Value to Revenue (EV/Rev)	0.00	0.56	1.20	0.83	0.36	0.41
Enterprise Value to EBITDA (EV/EBITDA)	0.00	7.05	14.50	12.18	0.00	11.50
Enterprise Value to EBIT (EV/EBIT)	0.00	14.26	23.09	23.56	0.00	210.08
Enterprise Value to NOPAT (EV/NOPAT)	0.00	20.37	35.45	32.45	0.00	504.42
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	10.32	19.38	14.49	10.32	14.01
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	6.27	0.00	6.30	19.95
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.80	0.73	0.69	1.34	1.42
Long-Term Debt to Equity	0.00	0.80	0.73	0.68	1.33	1.42
Financial Leverage	0.00	0.75	0.46	0.40	0.82	1.26
Leverage Ratio	0.00	2.96	2.68	2.61	3.36	4.59
Compound Leverage Factor	0.00	-0.63	1.80	1.37	3.78	-49.61
Debt to Total Capital	0.00%	44.51%	42.10%	40.94%	57.34%	58.71%
Short-Term Debt to Total Capital	0.00%	0.06%	0.00%	0.57%	0.57%	0.20%
Long-Term Debt to Total Capital	0.00%	44.45%	42.10%	40.38%	56.77%	58.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	-0.37%	-0.47%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	55.86%	58.36%	59.06%	42.66%	41.29%
Debt to EBITDA	0.00	4.19	3.43	4.01	-1.64	7.31
Net Debt to EBITDA	0.00	3.91	2.98	3.52	-1.51	6.55
Long-Term Debt to EBITDA	0.00	4.18	3.43	3.96	-1.63	7.29
Debt to NOPAT	0.00	12.11	8.38	10.68	-1.93	320.81
Net Debt to NOPAT	0.00	11.29	7.30	9.38	-1.78	287.23
Long-Term Debt to NOPAT	0.00	12.10	8.38	10.54	-1.91	319.73
Altman Z-Score	0.00	1.08	2.06	1.57	0.24	0.99
Noncontrolling Interest Sharing Ratio	0.00%	-0.66%	-0.74%	-0.39%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	0.89	1.02	0.99	0.86	0.85
Quick Ratio	0.00	0.18	0.25	0.25	0.15	0.18
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3,456	1,107	-995	353	125
Operating Cash Flow to CapEx	70.32%	171.90%	149.95%	125.51%	95.62%	140.32%
Free Cash Flow to Firm to Interest Expense	0.00	-14.61	11.27	-9.79	2.33	0.87
Operating Cash Flow to Interest Expense	0.44	1.14	3.65	3.40	1.42	1.24
Operating Cash Flow Less CapEx to Interest Expense	-0.18	0.47	1.21	0.69	-0.07	0.36
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.81	1.01	1.00	1.04	1.16
Accounts Receivable Turnover	0.00	117.63	119.19	114.75	133.16	144.27
Inventory Turnover	0.00	5.22	5.57	5.44	5.84	5.67
Fixed Asset Turnover	0.00	7.84	8.57	7.89	7.72	7.93
Accounts Payable Turnover	0.00	8.29	9.09	9.19	9.01	7.75
Days Sales Outstanding (DSO)	0.00	3.10	3.06	3.18	2.74	2.53
Days Inventory Outstanding (DIO)	0.00	69.88	65.53	67.13	62.54	64.39
Days Payable Outstanding (DPO)	0.00	44.04	40.14	39.71	40.53	47.07
Cash Conversion Cycle (CCC)	0.00	28.94	28.45	30.61	24.75	19.85
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	3,592	2,681	3,831	2,651	2,531
Invested Capital Turnover	0.00	2.74	1.85	1.85	1.93	2.36
Increase / (Decrease) in Invested Capital	0.00	3,592	-911	1,149	-1,180	-120
Enterprise Value (EV)	0.00	2,773	6,941	5,015	2,226	2,490
Market Capitalization	864	1,249	5,530	3,566	760	1,072
Book Value per Share	$0.00	$9.82	$7.52	$7.84	$3.87	$3.55
Tangible Book Value per Share	$0.00	($5.39)	$0.30	($2.76)	($2.68)	($2.84)
Total Capital	0.00	3,704	3,896	4,033	2,777	2,697
Total Debt	0.00	1,648	1,640	1,651	1,592	1,583
Total Long-Term Debt	0.00	1,646	1,640	1,628	1,576	1,578
Net Debt	0.00	1,537	1,429	1,449	1,467	1,418
Capital Expenditures (CapEx)	157	156	239	276	226	127
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-207	-194	-184	-271	-326
Debt-free Net Working Capital (DFNWC)	0.00	-96	18	18	-145	-160
Net Working Capital (NWC)	0.00	-98	18	-5.26	-161	-166
Net Nonoperating Expense (NNE)	181	168	36	65	454	107
Net Nonoperating Obligations (NNO)	0.00	1,537	426	1,449	1,467	1,418
Total Depreciation and Amortization (D&A)	197	199	178	199	206	205
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-4.21%	-3.34%	-3.05%	-4.33%	-5.33%
Debt-free Net Working Capital to Revenue	0.00%	-1.94%	0.30%	0.29%	-2.33%	-2.62%
Net Working Capital to Revenue	0.00%	-1.99%	0.30%	-0.09%	-2.58%	-2.71%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.62	$0.34	($4.78)	($0.37)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	264.26M	265.52M	267.55M	273.41M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.62	$0.34	($4.78)	($0.37)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	265.34M	265.95M	267.55M	273.41M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	303.03M	304.55M	307.37M	315.13M
Normalized Net Operating Profit after Tax (NOPAT)	91	136	196	155	30	4.94
Normalized NOPAT Margin	2.05%	2.77%	3.37%	2.56%	0.47%	0.08%
Pre Tax Income Margin	-3.20%	-0.84%	3.49%	1.86%	-21.17%	-2.09%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.44	0.82	3.06	2.09	-7.74	0.08
NOPAT to Interest Expense	0.31	0.58	1.99	1.52	-5.44	0.03
EBIT Less CapEx to Interest Expense	-0.18	0.16	0.63	-0.62	-9.23	-0.80
NOPAT Less CapEx to Interest Expense	-0.31	-0.09	-0.44	-1.19	-6.93	-0.85
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-0.33%	2.41%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Petco Health and Wellness' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/29/2022	1/28/2023	4/29/2023	7/29/2023	10/28/2023	2/3/2024	5/4/2024	8/3/2024	11/2/2024	2/1/2025	5/3/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.02%	4.20%	5.41%	3.37%	-0.47%	6.12%	-1.72%	-0.46%	1.16%	-7.31%	-2.34%
EBITDA Growth	-22.13%	-3.96%	-17.79%	-15.49%	-1,305.47%	-57.32%	-61.25%	-29.46%	105.40%	26.58%	113.57%
EBIT Growth	-40.49%	-10.43%	-39.43%	-35.01%	-2,633.41%	-99.78%	-163.89%	-90.45%	101.01%	9,772.29%	184.12%
NOPAT Growth	-19.44%	-13.93%	-42.53%	-46.80%	-2,326.67%	-99.77%	-160.77%	-89.73%	100.32%	10,374.70%	197.48%
Net Income Growth	-61.33%	19.95%	-107.95%	-208.55%	-6,330.61%	-168.97%	-2,356.82%	-69.95%	98.66%	38.71%	74.91%
EPS Growth	-65.00%	18.18%	-111.11%	-200.00%	-6,714.29%	-169.23%	-1,600.00%	-80.00%	98.70%	44.44%	76.47%
Operating Cash Flow Growth	27.12%	95.70%	-34.54%	126.96%	-68.52%	-65.56%	-122.35%	-28.20%	-39.81%	104.14%	-83.67%
Free Cash Flow Firm Growth	96.36%	-213.26%	38.60%	187.29%	356.29%	207.38%	1,373.89%	11.07%	-85.92%	-88.81%	-91.43%
Invested Capital Growth	4.65%	42.86%	3.04%	-22.46%	-31.31%	-30.79%	-31.51%	-32.61%	-1.70%	-4.52%	-3.47%
Revenue Q/Q Growth	1.38%	5.11%	-1.40%	-1.62%	-2.39%	12.07%	-8.68%	-0.35%	-0.81%	2.69%	-3.78%
EBITDA Q/Q Growth	9.28%	28.44%	-35.64%	-6.46%	-1,658.88%	104.55%	-41.57%	70.30%	19.43%	6.52%	-1.42%
EBIT Q/Q Growth	22.35%	52.71%	-59.02%	-15.13%	-4,869.36%	100.01%	-11,815.06%	112.69%	404.13%	31.72%	-0.18%
NOPAT Q/Q Growth	22.47%	31.08%	-61.93%	-12.96%	-5,225.99%	100.01%	-10,209.64%	114.71%	61.14%	337.21%	-5.92%
Net Income Q/Q Growth	48.04%	64.32%	-105.78%	-671.99%	-8,397.45%	98.18%	-105.90%	46.60%	32.83%	17.01%	15.73%
EPS Q/Q Growth	40.00%	85.71%	-107.69%	-400.00%	-9,160.00%	98.06%	-88.89%	47.06%	33.33%	16.67%	20.00%
Operating Cash Flow Q/Q Growth	156.94%	24.84%	-72.42%	156.60%	-64.36%	36.57%	-117.89%	924.46%	-70.13%	363.20%	-116.10%
Free Cash Flow Firm Q/Q Growth	89.80%	-733.97%	91.37%	1,289.58%	-70.06%	249.42%	2.37%	3.72%	-96.20%	177.79%	-21.61%
Invested Capital Q/Q Growth	-22.50%	-0.06%	1.03%	-0.90%	-31.35%	0.69%	-0.02%	-2.50%	0.14%	-2.20%	1.08%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.81%	39.75%	38.85%	38.74%	36.81%	36.21%	37.84%	38.11%	38.09%	37.96%	38.17%
EBITDA Margin	6.52%	7.97%	5.20%	4.95%	-78.98%	3.21%	2.05%	3.50%	4.22%	4.38%	4.48%
Operating Margin	3.20%	4.92%	1.78%	1.57%	-82.46%	0.01%	-1.10%	0.16%	0.26%	1.12%	1.10%
EBIT Margin	3.24%	4.71%	1.96%	1.69%	-82.46%	0.01%	-1.27%	0.16%	0.82%	1.06%	1.10%
Profit (Net Income) Margin	1.33%	2.07%	-0.12%	-0.95%	-83.07%	-1.35%	-3.04%	-1.63%	-1.10%	-0.89%	-0.78%
Tax Burden Percent	92.85%	77.70%	31.38%	130.39%	97.91%	57.64%	83.23%	73.74%	75.76%	84.14%	73.92%
Interest Burden Percent	44.12%	56.72%	-19.81%	-43.36%	102.89%	-23,593.98%	287.17%	-1,364.06%	-176.89%	-100.35%	-96.44%
Effective Tax Rate	19.40%	34.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.11%	5.97%	1.99%	1.54%	-109.96%	0.01%	-1.47%	0.22%	0.44%	1.85%	1.79%
ROIC Less NNEP Spread (ROIC-NNEP)	2.83%	4.04%	0.55%	0.01%	-135.67%	-1.54%	-3.82%	-1.63%	-0.90%	0.05%	0.22%
Return on Net Nonoperating Assets (RNNOA)	1.84%	1.63%	0.34%	0.00%	-113.50%	-1.26%	-3.17%	-1.32%	-1.13%	0.06%	0.28%
Return on Equity (ROE)	5.95%	7.60%	2.34%	1.55%	-223.46%	-1.25%	-4.64%	-1.10%	-0.69%	1.91%	2.07%
Cash Return on Invested Capital (CROIC)	-0.20%	-30.55%	0.62%	27.21%	13.24%	10.90%	11.10%	11.79%	1.44%	4.82%	4.61%
Operating Return on Assets (OROA)	2.97%	4.70%	1.83%	1.58%	-84.61%	0.01%	-1.34%	0.17%	0.97%	1.22%	1.28%
Return on Assets (ROA)	1.21%	2.07%	-0.11%	-0.89%	-85.24%	-1.41%	-3.20%	-1.70%	-1.29%	-1.03%	-0.91%
Return on Common Equity (ROCE)	5.97%	7.63%	2.35%	1.55%	-223.46%	-1.25%	-4.64%	-1.10%	-0.69%	1.91%	2.07%
Return on Equity Simple (ROE_SIMPLE)	3.63%	0.00%	2.67%	1.50%	-102.69%	0.00%	-113.98%	-117.99%	-9.85%	0.00%	-6.05%
Net Operating Profit after Tax (NOPAT)	39	51	19	17	-862	0.12	-12	1.73	2.78	12	11
NOPAT Margin	2.58%	3.22%	1.24%	1.10%	-57.72%	0.01%	-0.77%	0.11%	0.18%	0.78%	0.77%
Net Nonoperating Expense Percent (NNEP)	1.28%	1.92%	1.45%	1.54%	25.71%	1.56%	2.35%	1.85%	1.34%	1.80%	1.57%
Return On Investment Capital (ROIC_SIMPLE)	-	1.26%	-	-	-	0.00%	-	-	-	0.45%	0.43%
Cost of Revenue to Revenue	60.19%	60.25%	61.15%	61.26%	63.19%	63.79%	62.16%	61.89%	61.91%	62.04%	61.83%
SG&A Expenses to Revenue	36.61%	34.84%	37.08%	37.17%	37.45%	36.20%	38.94%	37.95%	37.83%	36.84%	37.07%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.61%	34.84%	37.08%	37.17%	119.27%	36.20%	38.94%	37.95%	37.83%	36.84%	37.07%
Earnings before Interest and Taxes (EBIT)	49	74	30	26	-1,232	0.17	-19	2.47	12	16	16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	98	126	81	76	-1,180	54	31	53	64	68	67
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.38	1.50	1.26	1.05	0.84	0.64	0.41	0.80	1.25	0.96	0.87
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.54	0.59	0.50	0.41	0.16	0.12	0.08	0.14	0.22	0.18	0.16
Price to Earnings (P/E)	37.02	39.27	47.24	69.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.70%	2.55%	2.12%	1.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.23	1.31	1.16	1.03	0.93	0.84	0.74	0.91	1.11	0.98	0.94
Enterprise Value to Revenue (EV/Rev)	0.79	0.83	0.74	0.64	0.40	0.36	0.32	0.38	0.46	0.41	0.40
Enterprise Value to EBITDA (EV/EBITDA)	11.09	12.18	11.42	10.38	0.00	0.00	0.00	0.00	14.18	11.50	9.58
Enterprise Value to EBIT (EV/EBIT)	20.48	23.56	23.32	22.03	0.00	0.00	0.00	0.00	0.00	210.08	50.69
Enterprise Value to NOPAT (EV/NOPAT)	29.00	32.45	32.67	47.10	0.00	0.00	0.00	0.00	0.00	504.42	85.86
Enterprise Value to Operating Cash Flow (EV/OCF)	16.93	14.49	13.80	10.38	8.01	10.32	11.58	16.53	22.28	14.01	14.16
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	190.05	3.30	5.71	6.30	5.43	6.22	76.19	19.95	20.10
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.71	0.69	0.67	0.66	1.32	1.34	1.36	1.40	1.41	1.42	1.43
Long-Term Debt to Equity	0.70	0.68	0.67	0.66	1.32	1.33	1.35	1.39	1.40	1.42	1.43
Financial Leverage	0.65	0.40	0.63	0.87	0.84	0.82	0.83	0.81	1.25	1.26	1.30
Leverage Ratio	2.87	2.61	2.79	2.81	3.41	3.36	3.32	3.37	4.59	4.59	4.57
Compound Leverage Factor	1.27	1.48	-0.55	-1.22	3.51	-792.40	9.53	-45.92	-8.13	-4.61	-4.41
Debt to Total Capital	41.54%	40.94%	40.26%	39.76%	56.98%	57.34%	57.59%	58.28%	58.49%	58.71%	58.87%
Short-Term Debt to Total Capital	0.57%	0.57%	0.15%	0.13%	0.18%	0.57%	0.13%	0.19%	0.20%	0.20%	0.20%
Long-Term Debt to Total Capital	40.97%	40.38%	40.11%	39.63%	56.80%	56.77%	57.45%	58.09%	58.29%	58.51%	58.67%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	58.46%	59.06%	59.74%	60.24%	43.02%	42.66%	42.41%	41.72%	41.51%	41.29%	41.13%
Debt to EBITDA	3.88	4.01	4.10	4.19	-1.76	-1.64	-1.55	-1.52	7.82	7.31	6.29
Net Debt to EBITDA	3.53	3.52	3.73	3.74	-1.60	-1.51	-1.46	-1.39	7.25	6.55	5.76
Long-Term Debt to EBITDA	3.83	3.96	4.09	4.18	-1.75	-1.63	-1.54	-1.51	7.80	7.29	6.27
Debt to NOPAT	10.14	10.68	11.74	19.01	-2.05	-1.93	-1.84	-1.81	-222.22	320.81	56.33
Net Debt to NOPAT	9.23	9.38	10.66	16.95	-1.87	-1.78	-1.74	-1.67	-205.83	287.23	51.59
Long-Term Debt to NOPAT	10.01	10.54	11.70	18.95	-2.04	-1.91	-1.84	-1.81	-221.48	319.73	56.14
Altman Z-Score	1.42	1.50	1.43	1.33	0.24	0.97	0.91	0.97	1.06	1.00	0.99
Noncontrolling Interest Sharing Ratio	-0.36%	-0.39%	-0.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.96	0.99	0.98	0.95	0.90	0.86	0.85	0.84	0.84	0.85	0.85
Quick Ratio	0.18	0.25	0.20	0.22	0.17	0.15	0.12	0.16	0.14	0.18	0.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-132	-1,099	-95	1,128	338	1,180	1,208	1,252	48	132	104
Operating Cash Flow to CapEx	144.13%	207.71%	60.68%	185.89%	55.08%	95.84%	-25.78%	253.29%	67.33%	260.62%	-56.96%
Free Cash Flow to Firm to Interest Expense	-4.82	-33.41	-2.52	29.83	9.19	29.75	32.80	34.03	1.33	3.87	3.09
Operating Cash Flow to Interest Expense	4.01	4.15	1.00	2.56	0.94	1.19	-0.23	1.88	0.58	2.81	-0.46
Operating Cash Flow Less CapEx to Interest Expense	1.23	2.15	-0.65	1.18	-0.76	-0.05	-1.12	1.14	-0.28	1.73	-1.27
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.92	1.00	0.94	0.93	1.03	1.04	1.05	1.04	1.17	1.16	1.17
Accounts Receivable Turnover	129.94	114.75	139.58	111.08	127.48	133.16	142.37	109.83	137.70	144.27	155.60
Inventory Turnover	5.17	5.44	5.47	5.35	5.21	5.84	5.78	5.80	5.49	5.67	5.68
Fixed Asset Turnover	8.10	7.89	7.90	7.75	7.61	7.72	7.83	7.88	7.96	7.93	8.20
Accounts Payable Turnover	9.25	9.19	9.39	8.37	8.69	9.01	9.09	8.20	8.34	7.75	8.02
Days Sales Outstanding (DSO)	2.81	3.18	2.62	3.29	2.86	2.74	2.56	3.32	2.65	2.53	2.35
Days Inventory Outstanding (DIO)	70.58	67.13	66.73	68.19	70.10	62.54	63.12	62.98	66.52	64.39	64.30
Days Payable Outstanding (DPO)	39.46	39.71	38.88	43.60	42.02	40.53	40.16	44.49	43.75	47.07	45.49
Cash Conversion Cycle (CCC)	33.92	30.61	30.47	27.88	30.95	24.75	25.52	21.80	25.41	19.85	21.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,833	3,831	3,870	3,835	2,633	2,651	2,651	2,585	2,588	2,531	2,559
Invested Capital Turnover	1.59	1.85	1.60	1.40	1.90	1.93	1.91	1.94	2.39	2.36	2.33
Increase / (Decrease) in Invested Capital	170	1,149	114	-1,111	-1,200	-1,180	-1,219	-1,251	-45	-120	-92
Enterprise Value (EV)	4,728	5,015	4,502	3,947	2,445	2,226	1,965	2,354	2,867	2,490	2,416
Market Capitalization	3,223	3,566	3,033	2,527	1,005	760	476	901	1,402	1,072	964
Book Value per Share	$7.67	$7.84	$7.88	$7.92	$3.90	$3.87	$3.78	$3.64	$3.60	$3.55	$3.51
Tangible Book Value per Share	($2.93)	($2.76)	($2.69)	($2.65)	($2.65)	($2.68)	($2.74)	($2.81)	($2.83)	($2.84)	($2.85)
Total Capital	3,982	4,033	4,019	4,008	2,773	2,777	2,740	2,712	2,705	2,697	2,692
Total Debt	1,654	1,651	1,618	1,594	1,580	1,592	1,578	1,581	1,582	1,583	1,585
Total Long-Term Debt	1,631	1,628	1,612	1,589	1,575	1,576	1,574	1,576	1,577	1,578	1,579
Net Debt	1,505	1,449	1,469	1,421	1,440	1,467	1,488	1,453	1,465	1,418	1,451
Capital Expenditures (CapEx)	76	66	62	52	63	49	33	27	31	37	27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-164	-184	-163	-218	-242	-271	-251	-298	-293	-326	-291
Debt-free Net Working Capital (DFNWC)	-16	18	-14	-45	-102	-145	-162	-171	-177	-160	-158
Net Working Capital (NWC)	-38	-5.26	-20	-50	-107	-161	-165	-176	-182	-166	-163
Net Nonoperating Expense (NNE)	19	18	21	31	379	23	35	27	19	26	23
Net Nonoperating Obligations (NNO)	1,505	1,449	1,469	1,421	1,440	1,467	1,488	1,453	1,465	1,418	1,451
Total Depreciation and Amortization (D&A)	49	51	50	50	52	54	51	51	51	52	51
Debt-free, Cash-free Net Working Capital to Revenue	-2.75%	-3.05%	-2.67%	-3.54%	-3.93%	-4.33%	-4.04%	-4.80%	-4.70%	-5.33%	-4.79%
Debt-free Net Working Capital to Revenue	-0.26%	0.29%	-0.23%	-0.73%	-1.66%	-2.33%	-2.60%	-2.75%	-2.83%	-2.62%	-2.59%
Net Working Capital to Revenue	-0.64%	-0.09%	-0.33%	-0.81%	-1.74%	-2.58%	-2.66%	-2.83%	-2.92%	-2.71%	-2.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.07	$0.13	($0.01)	($0.05)	($4.63)	($0.09)	($0.17)	($0.09)	($0.06)	($0.05)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	265.69M	265.52M	266.49M	267.16M	267.85M	267.55M	269.77M	273.07M	274.50M	273.41M	277.55M
Adjusted Diluted Earnings per Share	$0.07	$0.13	($0.01)	($0.05)	($4.63)	($0.09)	($0.17)	($0.09)	($0.06)	($0.05)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	265.94M	265.95M	266.49M	267.16M	267.85M	267.55M	269.77M	273.07M	274.50M	273.41M	277.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	303.71M	304.55M	304.80M	305.56M	306.28M	307.37M	310.78M	312.15M	313.45M	315.13M	316.78M
Normalized Net Operating Profit after Tax (NOPAT)	39	51	19	17	-6.73	0.12	-12	1.73	2.78	12	11
Normalized NOPAT Margin	2.58%	3.22%	1.24%	1.10%	-0.45%	0.01%	-0.77%	0.11%	0.18%	0.78%	0.77%
Pre Tax Income Margin	1.43%	2.67%	-0.39%	-0.73%	-84.84%	-2.34%	-3.65%	-2.21%	-1.46%	-1.06%	-1.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.78	2.26	0.81	0.68	-33.54	0.00	-0.53	0.07	0.35	0.48	0.49
NOPAT to Interest Expense	1.42	1.54	0.51	0.45	-23.48	0.00	-0.32	0.05	0.08	0.36	0.34
EBIT Less CapEx to Interest Expense	-1.00	0.26	-0.84	-0.69	-35.24	-1.23	-1.41	-0.68	-0.51	-0.60	-0.32
NOPAT Less CapEx to Interest Expense	-1.36	-0.46	-1.13	-0.93	-25.18	-1.23	-1.21	-0.70	-0.78	-0.72	-0.47
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Key Financial Trends

Petco’s Q1 2025 results showed continued pressure on top‐line and cash flows, though valuation and leverage metrics improved sequentially. Here are the 10 most important takeaways:

Attractive valuation: EV/EBITDA down to 9.6× in Q1 from 11.5× in Q4 2024; EV/Revenue at 0.397× vs. 0.407×
Improved leverage: net debt-to-EBITDA fell to 5.76× from 6.55×
EPS loss narrowed to –$0.04 from –$0.05 in the prior quarter
EBITDA margin ticked up to 4.48% from 4.38%
Price-to-book ratio remains low at 0.87×
Revenue down 2.3% year-over-year in Q1 2025
Operating cash flow turned negative at –$15.5 M vs. +$96.0 M in Q4 2024
Free cash flow to firm fell to $103.5 M from $132.0 M in the prior quarter
Net loss of $11.7 M, albeit slightly improved from a $13.8 M loss
Profit margin remained negative at –0.78%; cash conversion cycle extended to 21.2 days

06/23/25 09:06 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Petco Health and Wellness' Financials

When does Petco Health and Wellness' fiscal year end?

According to the most recent income statement we have on file, Petco Health and Wellness' financial year ends in February. Their financial year 2025 ended on February 1, 2025.

How has Petco Health and Wellness' net income changed over the last 5 years?

Petco Health and Wellness' net income appears to be on an upward trend, with a most recent value of -$101.82 million in 2024, falling from -$103.98 million in 2019. The previous period was -$1.28 billion in 2023. View Petco Health and Wellness' forecast to see where analysts expect Petco Health and Wellness to go next.

What is Petco Health and Wellness' operating income?

Petco Health and Wellness' total operating income in 2024 was $7.05 million, based on the following breakdown:

Total Gross Profit: $2.32 billion
Total Operating Expenses: $2.32 billion

How has Petco Health and Wellness' revenue changed over the last 5 years?

Over the last 5 years, Petco Health and Wellness' total revenue changed from $4.43 billion in 2019 to $6.12 billion in 2024, a change of 37.9%.

How much debt does Petco Health and Wellness have?

Petco Health and Wellness' total liabilities were at $4.08 billion at the end of 2024, a 2.3% decrease from 2023, and a 1.5% increase since 2020.

How much cash does Petco Health and Wellness have?

In the past 4 years, Petco Health and Wellness' cash and equivalents has ranged from $111.40 million in 2020 to $211.60 million in 2021, and is currently $165.76 million as of their latest financial filing in 2024.

How has Petco Health and Wellness' book value per share changed over the last 5 years?

Over the last 5 years, Petco Health and Wellness' book value per share changed from 0.00 in 2019 to 3.55 in 2024, a change of 355.3%.

Related Companies

This page (NASDAQ:WOOF) was last updated on 6/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Petco Health and Wellness (WOOF) Financials

Key Financial Trends

Frequently Asked Questions About Petco Health and Wellness' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Petco Health and Wellness (WOOF) Financials

Annual Income Statements for Petco Health and Wellness

Quarterly Income Statements for Petco Health and Wellness

Annual Cash Flow Statements for Petco Health and Wellness

Quarterly Cash Flow Statements for Petco Health and Wellness

Annual Balance Sheets for Petco Health and Wellness

Quarterly Balance Sheets for Petco Health and Wellness

Annual Metrics And Ratios for Petco Health and Wellness

Quarterly Metrics And Ratios for Petco Health and Wellness

Key Financial Trends

Frequently Asked Questions About Petco Health and Wellness' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools